EUVIMEDEUVIMED entdecken
Crossref

Robust Predictive Performance of the SALT ‐M Score for Clinical Outcomes in Asian Patients With Acute‐on‐Chronic Liver Failure

Kunhee Kim iD, Seung Hyuk Yim, Jae Geun Lee iD, Dong Jin Joo, Myoung Soo Kim iD, Jun Yong Park, Sang Hoon Ahn iD, Deok-Gie Kim iD, Hye Won Lee iD

Alimentary Pharmacology & Therapeutics · 2025-01 · 61 (1) · 168-176

DOI: 10.1111/apt.18335 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 11.10.2024. Verfasst von Kunhee Kim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Acute-On-Chronic Liver Failure, Liver Transplantation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Daewoong Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acute‐on‐chronic liver failure (ACLF) is a syndrome of patients with chronic liver disease presenting with multiple organ failures. Recently, Sundaram‐ACLF‐LT Mortality (SALT‐M) score has been developed to predict 1‐year post‐liver transplantation mortality. We validated the SALT‐M score in a large‐volume, Asian single‐centre cohort.

Aims

We validated the SALT‐M score in a large‐volume, Asian single‐centre cohort.

Methods

We analysed 224 patients of ACLF grade 2–3. Area under the receiver operating characteristic curve (AUROC) and concordance index (c‐index) were used to assess and compare the predictability of posttransplant mortality of SALT‐M and other scores. Moreover, we compared the survivals of patients with high and low SALT‐M, in conjunction with MELD score and ACLF grade.

Results

The AUROC for prediction of 1‐year post‐LT survival was higher in SALT‐M (0.691) than in MELD, MELD‐Na, MELD 3.0 and delta‐MELD. Similarly, the c‐index of the SALT‐M (0.650) was higher than aforementioned MELD systems. When categorised by the cut‐off of SALT‐M ≥ 20 and MELD ≥ 30, patients with high SALT‐M exhibited lower post‐LT survival than those with low SALT‐M scores regardless of high or low MELD (40.0% for high SALT‐M/high MELD vs. 42.9% for high SALT‐M/low MELD vs. 73.8% for low SALT‐M/high MELD vs. 63.7% for low SALT‐M/low MELD, p < 0.001). In patients with ACLF grade 3, SALT‐M effectively stratified the posttransplant mortality (39.4% for high SALT‐M vs. 63.1% for low SALT‐M, p = 0.018).

Conclusions

SALT‐M outperformed previous MELD systems for predicting posttransplant mortality in Asian LT cohort with severe ACLF. Transplantability for patients with severe ACLF could be determined based on SALT‐M.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute-On-Chronic Liver FailureLiver TransplantationHumansMaleFemaleMiddle AgedAdultSeverity of Illness IndexPrognosisROC CurveAsian PeoplePredictive Value of TestsRetrospective StudiesCohort Studies

Stichwörter der Autor:innen

AsianSALT‐M scoreacute‐on‐chronic liver failureliver transplantation

Autor:innen und Institutionen

  • Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
  • Department of Surgery, Institute for Transplantation, Yonsei University College of Medicine, Seoul, South Korea.
  • Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, South Korea.
  • Yonsei Liver Center, Severance Hospital, Seoul, South Korea.

ORCID-Profile: Kunhee Kim, Jae Geun Lee, Myoung Soo Kim, Sang Hoon Ahn, Deok-Gie Kim, Hye Won Lee

Förderung

  • Daewoong Foundation

Zitieren

APA

Kim, K., Yim, S. H., Lee, J. G., Joo, D. J., Kim, M. S., Park, J. Y., Ahn, S. H., Kim, D. G., & Lee, H. W. (2025). Robust Predictive Performance of the SALT ‐M Score for Clinical Outcomes in Asian Patients With Acute‐on‐Chronic Liver Failure. Alimentary Pharmacology & Therapeutics, 61(1), 168-176. https://doi.org/10.1111/apt.18335

Vancouver

Kim K, Yim SH, Lee JG, Joo DJ, Kim MS, Park JY, et al. Robust Predictive Performance of the SALT ‐M Score for Clinical Outcomes in Asian Patients With Acute‐on‐Chronic Liver Failure. Alimentary Pharmacology & Therapeutics. 2025;61(1):168-176. doi:10.1111/apt.18335

BibTeX
@article{Kim2025,
  author = {Kim, Kunhee and Yim, Seung Hyuk and Lee, Jae Geun and Joo, Dong Jin and Kim, Myoung Soo and Park, Jun Yong and Ahn, Sang Hoon and Kim, Deok-Gie and Lee, Hye Won},
  title = {Robust Predictive Performance of the SALT ‐M Score for Clinical Outcomes in Asian Patients With Acute‐on‐Chronic Liver Failure},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2025},
  volume = {61},
  number = {1},
  pages = {168--176},
  doi = {10.1111/apt.18335}
}
Kostenlos starten →